Segment Wealth Management’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.45M Buy
97,135
+9,900
+11% +$249K 0.13% 110
2026
Q1
$2.2M Buy
87,235
+21,385
+32% +$546K 0.13% 114
2025
Q4
$1.68M Buy
65,850
+5,840
+10% +$149K 0.1% 115
2025
Q3
$1.54M Buy
60,010
+2,800
+5% +$71.1K 0.09% 125
2025
Q2
$1.45M Buy
57,210
+2,250
+4% +$55.8K 0.09% 132
2025
Q1
$1.37M Buy
54,960
+6,020
+12% +$149K 0.09% 126
2024
Q4
$1.2M Buy
48,940
+21,980
+82% +$550K 0.08% 135
2024
Q3
$693K Buy
26,960
+940
+4% +$23.7K 0.05% 169
2024
Q2
$639K Buy
26,020
+2,450
+10% +$59.8K 0.05% 171
2024
Q1
$585K Buy
23,570
+14,870
+171% +$368K 0.04% 176
2023
Q4
$220K Buy
+8,700
New +$208K 0.02% 236

Other funds holding IBDX

Segment Wealth Management's IBDX Position: Q2 2026 in Review

Segment Wealth Management increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 11% in Q2 2026, buying an estimated $249K and bringing the position to 97,135 shares worth $2.45M. The position accounts for 0.13% of the portfolio, ranked #110.

Segment Wealth Management first reported a position in IBDX in Q4 2023 and has held it in 11 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Segment Wealth Management held 97,135 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $2.45M as of Q2 2026.
  • Segment Wealth Management bought 9,900 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $249K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.13% of Segment Wealth Management's portfolio in Q2 2026, its #110 holding.
  • Segment Wealth Management first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Segment Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.